Abstract:This study explores the use of bacteria to mitigate ibuprofen (IBU) contamination in wastewater. Four new bacterial strains were identified that can grow with IBU as the only carbon source and demonstrated significant IBU removal efficiencies. In‐depth analysis revealed that two strains, Klebsiella pneumoniae TIBU2.1 and Mycolicibacterium aubagnense HPB1.1, possess genes encoding proteins similar to enzymes involved in IBU degradation, providing a promising avenue for bioremediation in IBU‐contaminated environments. Ibuprofen (IBU) is a significant contaminant frequently found in wastewater treatment plants due to its widespread use and limited removal during treatment processes. This leads to its discharge into the environment, causing considerable environmental concerns. The use of microorganisms has recently been recognized as a sustainable method for mitigating IBU contamination in wastewater. In this study, new bacteria capable of growing in a solid medium with IBU as the only carbon source and removing IBU from a liquid medium were isolated from environmental samples, including soil, marine, mine, and olive mill wastewater. Four bacterial strains, namely Klebsiella pneumoniae TIBU2.1, Klebsiella variicola LOIBU1.1, Pseudomonas aeruginosa LOIBU1.2, and Mycolicibacterium aubagnense HPB1.1, were identified through 16S rRNA gene sequencing. These strains demonstrated significant IBU removal efficiencies, ranging from 60 to 100% within 14 days, starting from an initial IBU concentration of 5 mg per litre. These bacteria have not been previously reported in the literature as IBU degraders, making this work a valuable contribution to further studies in the field of bioremediation in environments contaminated by IBU. Based on the IBU removal results, the most promising bacteria, K. pneumoniae TIBU2.1 and M. aubagnense HPB1.1, were selected for an in silico analysis to identify genes potentially involved in IBU biodegradation. Interestingly, in the tests with TIBU2.1, a peak of IBU transformation product(s) was detected by high‐performance liquid chromatography, while in the tests with HPB1.1, it was not detected. The emerging peak was analysed by liquid chromatography–mass spectrometry, indicating the presence of possible conjugates between intermediates of IBU biodegradation. The proteins encoded on their whole‐genome sequences were aligned with proteins involved in an IBU‐degrading pathway reported in bacteria with respective catabolic genes. The analysis indicated that strain HPB1.1 possesses genes encoding proteins similar to most enzymes reported associated with the IBU metabolic pathways used as reference bacteria, while strain TIBU2.1 has genes encoding proteins similar to enzymes involved in both the upper and the lower part of that pathway. Notably, in the tests with the strain having more candidate genes encoding IBU‐catabolic enzymes, no IBU transformation products were detected, while in the tests with the strain having fewer of these genes, detection occurred.

Ibuprofen degradation by mixed bacterial consortia: Metabolic pathway and microbial community analysis

Transformation of the drug ibuprofen by : Reversible glycosylation and generation of hydroxylated metabolites

Aerobic degradation of ibuprofen in batch and continuous reactors by an indigenous bacterial community

Ibuprofen-enhanced biodegradation in solution and sewage sludge by a mineralizing microbial consortium. Shift in associated bacterial communities

Identification of a Novel Ibuprofen Biotransformation Pathway in Streptomyces sp. D218 and Detoxification as Indicated by the Green Algae Scenedesmus obliquus

High-throughput Pyrosequencing Analysis of Bacteria Relevant to Cometabolic and Metabolic Degradation of Ibuprofen in Horizontal Subsurface Flow Constructed Wetlands.

Marine bacteria-mediated abiotic-biotic coupling degradation mechanism of ibuprofen

New bacterial strains for ibuprofen biodegradation: Drug removal, transformation, and potential catabolic genes

Analyzing microbial communities and their biodegradation of multiple pharmaceuticals in membrane bioreactors

Delineating acetaminophen biodegradation kinetics and metabolomics using bacterial community

Changes in Ibuprofen Toxicity and Degradation in Response to Immobilization of Bacillus thuringiensis B1(2015b)

Responses of microbial communities and their interactions to ibuprofen in a bio-electrochemical system

Complete Biodegradation of Diclofenac by New Bacterial Strains: Postulated Pathways and Degrading Enzymes

Biodegradation and Kinetic Analysis of Acetaminophen with Co-culture of Bacterial Strains Isolated from Sewage Wastewater

Biodegradation of Microtoxic Phenylpropanoids (Phenylpropanoic Acid and Ibuprofen) by Bacteria and the Relevance for Their Removal from Wastewater Treatment Plants

Insights into the biodegradation of fipronil through soil microcosm-omics analyses of Pseudomonas sp. FIP_ A4

Studies on Biodegradation of Acetaminophen by Bacillus subtilis subsp. subtilis NCIB 3610(T)

Elucidating Degradation Mechanisms Of Florfenicol In Soil By Stable-Isotope Assisted Nontarget Screening

Optimization of degradation of ciprofloxacin antibiotic and assessment of degradation products using full factorial experimental design by Fenton Homogenous process

Degradation of Ibuprofen by the Electro/Fe3+/Peroxydisulfate Process: Reactive Kinetics, Degradation Products and Mechanism

Biodegradation Pathway and Detoxification of β-cyfluthrin by the Bacterial Consortium and Its Bacterial Community Structure